1. |
CD46 expression and HHV-6 infection in patients with multiple sclerosis. |
Alvarez-Lafuente R, etal., Acta Neurol Scand. 2009 Oct;120(4):246-50. Epub 2009 May 13.
|
2. |
CD46 in a Spanish cohort of multiple sclerosis patients: genetics, mRNA expression and response to interferon-beta treatment. |
Alvarez-Lafuente R, etal., Mult Scler. 2011 May;17(5):513-20. Epub 2010 Dec 21.
|
3. |
Prevalence of anti human herpes virus-6 IgG and its receptor in acute leukemia (membrane cofactor protein: MCP, CD46). |
Assem MM, etal., J Egypt Natl Canc Inst. 2005 Mar;17(1):29-34.
|
4. |
Expression and significance of leukocyte membrane cofactor protein transcript in systemic lupus erythematosus. |
Biswas B, etal., Lupus. 2012 Apr;21(5):517-25. Epub 2012 Jan 13.
|
5. |
Ascitic complement system in ovarian cancer. |
Bjorge L, etal., Br J Cancer. 2005 Mar 14;92(5):895-905.
|
6. |
A possible role of CD46 for the protection in vivo of human renal tumor cells from complement-mediated damage. |
Blok VT, etal., Lab Invest. 2000 Mar;80(3):335-44.
|
7. |
Expression of innate immune complement regulators on brain epithelial cells during human bacterial meningitis. |
Canova C, etal., J Neuroinflammation. 2006 Sep 2;3:22.
|
8. |
Atypical haemolytic uraemic syndrome and mutations in complement regulator genes. |
Dragon-Durey MA and Fremeaux-Bacchi V, Springer Semin Immunopathol. 2005 Nov;27(3):359-74. Epub 2005 Nov 11.
|
9. |
Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. |
Fang CJ, etal., Blood. 2008 Jan 15;111(2):624-32. Epub 2007 Oct 3.
|
10. |
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. |
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
|
11. |
Rat ISS GO annotations from GOA human gene data--August 2006 |
GOA data from the GO Consortium
|
12. |
CD46 protects against chronic obstructive pulmonary disease. |
Grumelli S, etal., PLoS One. 2011 May 6;6(5):e18785.
|
13. |
High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: a preventive mechanism of malignant tumor cells against complement attack? |
Hofman P, etal., Breast Cancer Res Treat. 1994;32(2):213-9.
|
14. |
CD46 in meningococcal disease. |
Johansson L, etal., Science. 2003 Jul 18;301(5631):373-5.
|
15. |
Activation of intrarenal complement system in mouse model for chronic cyclosporine nephrotoxicity. |
Kim YO, etal., Yonsei Med J. 2007 Jun 30;48(3):517-25.
|
16. |
Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolism. |
Lewis DA, etal., Thromb Res. 2015 Apr;135(4):659-65. doi: 10.1016/j.thromres.2015.02.003. Epub 2015 Feb 7.
|
17. |
Genetic analysis of membrane cofactor protein (CD46) of the complement system in women with and without preeclamptic pregnancies. |
Lokki AI, etal., PLoS One. 2015 Feb 24;10(2):e0117840. doi: 10.1371/journal.pone.0117840. eCollection 2015.
|
18. |
Do poor-prognosis breast tumours express membrane cofactor proteins (CD46)? |
Madjd Z, etal., Cancer Immunol Immunother. 2005 Feb;54(2):149-56. Epub 2004 Sep 16.
|
19. |
Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. |
Maga TK, etal., Hum Mutat. 2010 Jun;31(6):E1445-60. doi: 10.1002/humu.21256.
|
20. |
Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. |
Marie JC, etal., Nat Immunol. 2002 Jul;3(7):659-66. Epub 2002 Jun 10.
|
21. |
Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46). |
Mead R, etal., Immunology. 1999 Sep;98(1):137-43.
|
22. |
Rat ISS GO annotations from MGI mouse gene data--August 2006 |
MGD data from the GO Consortium
|
23. |
Molecular cloning of rat and mouse membrane cofactor protein (MCP, CD46): preferential expression in testis and close linkage between the mouse Mcp and Cr2 genes on distal chromosome 1. |
Miwa T, etal., Immunogenetics 1998 Nov-Dec;48(6):363-71.
|
24. |
Rat membrane cofactor protein (MCP; CD46) is expressed only in the acrosome of developing and mature spermatozoa and mediates binding to immobilized activated C3. |
Mizuno M, etal., Biol Reprod. 2004 Oct;71(4):1374-83. Epub 2004 Jun 23.
|
25. |
Expression of CD46 in developing rat spermatozoa: ultrastructural localization and utility as a marker of the various stages of the seminiferous tubuli. |
Mizuno M, etal., Biol Reprod. 2005 Apr;72(4):908-15. Epub 2004 Dec 15.
|
26. |
Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue. |
Murray KP, etal., Gynecol Oncol. 2000 Feb;76(2):176-82.
|
27. |
Electronic Transfer of LocusLink and RefSeq Data |
NCBI rat LocusLink and RefSeq merged data July 26, 2002
|
28. |
Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. |
Noris M, etal., Clin J Am Soc Nephrol. 2010 Oct;5(10):1844-59. doi: 10.2215/CJN.02210310. Epub 2010 Jul 1.
|
29. |
Familial haemolytic uraemic syndrome and an MCP mutation. |
Noris M, etal., Lancet. 2003 Nov 8;362(9395):1542-7.
|
30. |
Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections. |
Nuutila J, etal., Hum Immunol. 2013 May;74(5):522-30. doi: 10.1016/j.humimm.2013.01.011. Epub 2013 Jan 29.
|
31. |
OMIM Disease Annotation Pipeline |
OMIM Disease Annotation Pipeline
|
32. |
Oncolytic measles virus targets high CD46 expression on multiple myeloma cells. |
Ong HT, etal., Exp Hematol. 2006 Jun;34(6):713-20.
|
33. |
Intraperitoneal therapy of ovarian cancer using an engineered measles virus. |
Peng KW, etal., Cancer Res. 2002 Aug 15;62(16):4656-62.
|
34. |
KEGG Annotation Import Pipeline |
Pipeline to import KEGG annotations from KEGG into RGD
|
35. |
GOA pipeline |
RGD automated data pipeline
|
36. |
ClinVar Automated Import and Annotation Pipeline |
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
|
37. |
Data Import for Chemical-Gene Interactions |
RGD automated import pipeline for gene-chemical interactions
|
38. |
Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. |
Richards A, etal., Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12966-71. Epub 2003 Oct 17.
|
39. |
Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. |
Salmon JE, etal., PLoS Med. 2011 Mar;8(3):e1001013. Epub 2011 Mar 22.
|
40. |
Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease. |
Simpson KL, etal., Am J Pathol. 1997 Nov;151(5):1455-67.
|
41. |
CD46 expression is indicative of shorter revival-free survival for ovarian cancer patients. |
Surowiak P, etal., Anticancer Res. 2006 Nov-Dec;26(6C):4943-8.
|
42. |
Complement inhibitory proteins expression in placentas of thrombophilic women. |
Wirstlein PK, etal., Folia Histochem Cytobiol. 2012 Oct 8;50(3):460-7. doi: 10.5603/19758.
|
43. |
Expression of decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 in the human astroglioma cell line, D54-MG, and primary rat astrocytes. |
Yang C, etal., J Neuroimmunol. 1993 Sep;47(2):123-32.
|
44. |
A CD46 transgenic mouse model for studying the histopathology of arthritis caused by subcutaneous infection with Streptococcus dysgalactiae subspecies equisimilis. |
Yoshida H, etal., J Med Microbiol. 2011 Dec;60(Pt 12):1860-8. Epub 2011 Aug 18.
|
45. |
Effect of IL-4 on altered expression of complement activation regulators in rat pancreatic cells during severe acute pancreatitis. |
Zhang C, etal., World J Gastroenterol. 2005 Nov 21;11(43):6770-4.
|